San Diego, CA, United States of America

Belen Ybarrondo

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Belen Ybarrondo: Innovator in Cancer Therapy

Introduction

Belen Ybarrondo is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of cancer research, particularly in developing methods for predicting responses to cancer therapies. With a total of 4 patents, her work is paving the way for advancements in cancer diagnosis and treatment.

Latest Patents

One of her latest patents is titled "Methods for predicting response of triple-negative breast cancer to therapy." This invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells, specifically targeting triple-negative metastatic breast tumor cells. The information derived from this invention can be utilized for cancer diagnosis, prognosis, and the design of effective cancer treatments. Another notable patent is "Drug selection for gastric cancer therapy using antibody-based arrays." This invention offers methods for selecting suitable anticancer therapies and for identifying and predicting responses to treatments for gastric cancer.

Career Highlights

Belen has worked with notable companies such as Nestlé S.A. and Pierian Holdings, Inc. Her experience in these organizations has contributed to her expertise in the field of cancer research and therapy development.

Collaborations

Throughout her career, Belen has collaborated with esteemed colleagues, including Xinjun Liu and Phillip Kim. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Belen Ybarrondo is a dedicated inventor whose work in cancer therapy is making a significant impact. Her innovative patents and collaborations are essential in advancing the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…